These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11773151)

  • 1. Phase II trial of biweekly administration of vinorelbine and gemcitabine in pretreated advanced breast cancer.
    Stathopoulos GP; Rigatos SK; Pergantas N; Tsavdarides D; Athanasiadis I; Malamos NA; Stathopoulos JG
    J Clin Oncol; 2002 Jan; 20(1):37-41. PubMed ID: 11773151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combination of gemcitabine and vinorelbine is an active regimen as second-line therapy in patients with metastatic breast cancer pretreated with taxanes and/or anthracyclines: a phase I-II study.
    Morabito A; Filippelli G; Palmeri S; Cascinu S; Ferraù F; Zagonel V; Gattuso D; Catalano V; Capaccetti B; Franciosi V; Accurso V; Scinto F; Gasparini G
    Breast Cancer Res Treat; 2003 Mar; 78(1):29-36. PubMed ID: 12611454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and toxicity of gemcitabine combined vinorelbine on metastatic breast cancer: a report of 34 cases].
    Zhou NN; Teng XY; Jiang WQ; Liu DG
    Ai Zheng; 2007 Dec; 26(12):1373-6. PubMed ID: 18076805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II study of gemcitabine combined with vinorelbine as first-line chemotherapy for metastatic breast cancer.
    Shehata S; Saad E; Goda Y; El-Mesidi S; Koheil H; Elzawhri H; Kandeel A; Abdelhamid T; Zaki M; Meshref M
    Hematol Oncol Stem Cell Ther; 2010; 3(1):1-6. PubMed ID: 20231807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cancer.
    Isokangas OP; Knuuttila A; Halme M; Mäntylä M; Lindström I; Nikkanen V; Viren M; Joensuu H; Mattson K
    Ann Oncol; 1999 Sep; 10(9):1059-63. PubMed ID: 10572603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group.
    Pectasides D; Kalofonos HP; Samantas E; Nicolaides C; Papacostas P; Onyenadum A; Visvikis A; Skarlos D; Fountzilas G
    Anticancer Res; 2001; 21(4B):3005-10. PubMed ID: 11712802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine as prolonged infusion and vinorelbine in anthracycline and/or taxane pretreated metastatic breast cancer: a phase II study.
    Schmid P; Heilmann V; Schulz CO; Dieing A; Lehenbauer-Dehm S; Jehn C; Sezer O; Possinger K; Flath B
    J Cancer Res Clin Oncol; 2005 Sep; 131(9):568-74. PubMed ID: 16044345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gefitinib in combination with gemcitabine and vinorelbine in patients with metastatic breast cancer pre-treated with taxane and anthracycline chemotherapy: a phase I/II trial.
    Gioulbasanis I; Saridaki Z; Kalykaki A; Vamvakas L; Kalbakis K; Ignatiadis M; Amarantidis K; Kakolyris S; Georgoulias V; Mavroudis D
    Anticancer Res; 2008; 28(5B):3019-25. PubMed ID: 19031950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy.
    Herbst RS; Khuri FR; Lu C; Liu DD; Fossella FV; Glisson BS; Pisters KM; Shin DM; Papadimitrakopoulou VA; Kurie JM; Blumenschein G; Kies MS; Zinner R; Jung MS; Lu R; Lee JJ; Munden RF; Hong WK; Lee JS
    Cancer; 2002 Jul; 95(2):340-53. PubMed ID: 12124835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine in combination with vinorelbine for heavily pretreated advanced breast cancer.
    Gennatas C; Michalaki V; Mouratidou D; Tsavaris N; Andreadis C; Psychogios J; Poulakaki N
    Anticancer Res; 2006; 26(1B):549-52. PubMed ID: 16739318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study.
    Donadio M; Ardine M; Berruti A; Ritorto G; Fea E; Mistrangelo M; Coccorullo Z; Bergnolo P; Comandone A; Bertetto O
    Cancer Chemother Pharmacol; 2003 Aug; 52(2):147-52. PubMed ID: 12764672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial.
    Martín M; Ruiz A; Muñoz M; Balil A; García-Mata J; Calvo L; Carrasco E; Mahillo E; Casado A; García-Saenz JA; Escudero MJ; Guillem V; Jara C; Ribelles N; Salas F; Soto C; Morales-Vasquez F; Rodríguez CA; Adrover E; Mel JR;
    Lancet Oncol; 2007 Mar; 8(3):219-25. PubMed ID: 17329192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes.
    Jones A; O'Brien M; Sommer H; Nowara E; Welt A; Pienkowski T; Rolski J; Pham ML; Perraud K; Trillet-Lenoir V
    Cancer Chemother Pharmacol; 2010 Mar; 65(4):755-63. PubMed ID: 19669644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancer.
    Morabito A; Longo R; Gattuso D; Carillio G; Massaccesi C; Mariani L; Bonginelli P; Amici S; De Sio L; Fanelli M; Torino F; Bonsignori M; Gasparini G
    Oncol Rep; 2006 Aug; 16(2):393-8. PubMed ID: 16820921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biweekly vinorelbine and gemcitabine: a phase I dose-finding study in patients with advanced solid tumors.
    Castellano D; Hitt R; Ciruelos E; Cortés-Funes H; Colomer R
    Ann Oncol; 2003 May; 14(5):783-7. PubMed ID: 12702534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biweekly vinorelbine and gemcitabine as second-line and beyond treatment in ovarian cancer.
    Xenidis N; Neanidis K; Amarantidis K; Dimopoulos P; Chamalidou E; Pitsiava D; Tentes A; Chatzaki E; Karakitsos P; Kakolyris S
    Cancer Chemother Pharmacol; 2011 Jan; 67(1):69-73. PubMed ID: 20221602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer.
    Stemmler HJ; diGioia D; Freier W; Tessen HW; Gitsch G; Jonat W; Brugger W; Kettner E; Abenhardt W; Tesch H; Hurtz HJ; Rösel S; Brudler O; Heinemann V
    Br J Cancer; 2011 Mar; 104(7):1071-8. PubMed ID: 21407218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vinorelbine Plus Gemcitabine or Cisplatin as First-line Treatment of HER2-negative Advanced Breast Cancer.
    He K; Wang X; Guan X; Yu Q; Ma Q; Liu Z; Yu Z
    Anticancer Res; 2017 Oct; 37(10):5647-5653. PubMed ID: 28982882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biweekly administration of gemcitabine and vinorelbine as first line therapy in elderly advanced breast cancer.
    Dinota A; Bilancia D; Romano R; Manzione L
    Breast Cancer Res Treat; 2005 Jan; 89(1):1-3. PubMed ID: 15666190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospective randomized phase III trial of the Gruppo Oncologico Italia Meridionale.
    Gebbia V; Galetta D; Caruso M; Verderame F; Pezzella G; Valdesi M; Borsellino N; Pandolfo G; Durini E; Rinaldi M; Loizzi M; Gebbia N; Valenza R; Tirrito ML; Varvara F; Colucci G;
    Lung Cancer; 2003 Feb; 39(2):179-89. PubMed ID: 12581571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.